Thymic output and peripheral T lymphocyte subsets in relapsing-remitting multiple sclerosis patients treated or not by IFN-β

被引:14
|
作者
Puissant-Lubrano, Benedicte [1 ,2 ]
Viala, Frederique
Winterton, Peter [2 ]
Abbal, Michel [1 ,2 ]
Clanet, Michel
Blancher, Antoine [1 ,2 ]
机构
[1] CHU Toulouse, Hop Rangueil, Immunol Lab, F-31059 Toulouse 9, France
[2] Univ Toulouse 3, Fac Med Toulouse Rangueil, Immunogenet Mol Lab, F-31062 Toulouse 4, France
关键词
multiple sclerosis; thymic function; regulatory T cells; IFN-beta treatment; T cell subsets; CD45RC;
D O I
10.1016/j.jneuroim.2007.10.027
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We explored the parameters of central and peripheral tolerance in patients with stable relapsing-remitting multiple sclerosis, treated or not with IFN-beta TREC-positive T cells were lower in patients compared with controls, mainly in CD4+ subset, compatible with a thymus dysfunction or an expansion of peripheral lymphocytes. Compared to controls, the frequency of activated CD4+CD25+ T cells was higher in patients without modification of the CD4+CD25(high) T cell proportion. The IFN-beta-treatment did not modify the TREC-positive cell frequency nor the naive/memory T cell subset percentage but was associated with lower blood lymphocyte count and a lower frequency of CD4+CD45RC(high) subset. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:188 / 194
页数:7
相关论文
共 50 条
  • [1] SERIAL EVALUATION OF PERIPHERAL-BLOOD LYMPHOCYTE-T SUBSETS IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE-SCLEROSIS
    KASTRUKOFF, LF
    PATY, DW
    ANNALS OF NEUROLOGY, 1982, 12 (01) : 103 - 103
  • [2] Development of neutralizing antibodies in patients with relapsing-remitting multiple sclerosis treated with IFN-β1a
    Antonelli, G
    Bagnato, F
    Pozzilli, C
    Simeoni, E
    Bastianelli, S
    Currenti, M
    De Pisa, F
    Fieschi, C
    Gasperini, C
    Salvetti, M
    Dianzani, F
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1998, 18 (05): : 345 - 350
  • [3] Neutralizing and binding antibodies to IFN-β:: Relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-β preparations
    Scagnolari, C
    Bellomi, F
    Turriziani, O
    Bagnato, F
    Tomassini, V
    Lavolpe, V
    Ruggieri, M
    Bruschi, F
    Meucci, G
    Dicuonzo, G
    Antonelli, G
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2002, 22 (02): : 207 - 213
  • [4] A SERIAL STUDY OF PERIPHERAL-BLOOD LYMPHOCYTE-T SUBSETS IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS
    KASTRUKOFF, LF
    PATY, DW
    ANNALS OF NEUROLOGY, 1984, 15 (03) : 250 - 256
  • [5] Gene expression profiling predicts response to therapy in IFN-β treated relapsing-remitting multiple sclerosis patients
    Comabella, M
    Mousavi, P
    Río, J
    Caillier, S
    Stillman, A
    Villoslada, P
    Wyatt, M
    Greller, L
    Somogyu, R
    Montalban, X
    Oksenberg, JR
    Baranzini, SE
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S109 - S109
  • [6] B Cells as a Therapeutic Target for IFN-β in Relapsing-Remitting Multiple Sclerosis
    Ramgolam, Vinod S.
    Sha, Yonggang
    Marcus, Karen L.
    Choudhary, Neelima
    Troiani, Luigi
    Chopra, Manisha
    Markovic-Plese, Silva
    JOURNAL OF IMMUNOLOGY, 2011, 186 (07): : 4518 - 4526
  • [7] Subcutaneous IFN-β1a to treat relapsing-remitting multiple sclerosis
    Thouvenot, Eric
    Carlander, Bertrand
    Camu, William
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (11) : 1283 - 1291
  • [8] IL-23/GM-CSF axis in IFN-β-treated relapsing-remitting multiple sclerosis patients
    Savic, Emina
    Markovic, Milos
    Drulovic, Jelena
    Pravica, Vera
    Ramic, Zorica
    Popadic, Dusan
    Mostarica-Stojkovic, Marija
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 253 (1-2) : 113 - 113
  • [9] Altered thymic output and possible patient heterogeneity in relapsing-remitting multiple sclerosis
    Duszczyszyn, D
    Beck, J
    Antel, J
    Bar-Or, A
    Lapierre, Y
    Haegert, D
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S163 - S163
  • [10] Lymphocyte subpopulation in patients with relapsing-remitting multiple sclerosis and SPMS
    Belniak, E.
    Bojarska-Junak, A.
    Mitosek-Szewczyk, K.
    Bartosik-Psujek, H.
    Stehmasiak, Z.
    Rolinski, J.
    MULTIPLE SCLEROSIS, 2007, 13 : S43 - S43